Esperion Therapeutics
ESPR
#6479
Rank
HK$6.28 B
Marketcap
HK$24.43
Share price
0.00%
Change (1 day)
328.69%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2025 (TTM): -HK$0.22 Billion

According to Esperion Therapeutics's latest financial reports the company's current earnings are HK$0.30 Billion. In 2024 the company made an earning of HK$58.76 Million, an increase over its 2023 earnings that were of -HK$1.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.22 Billion-462.25%
2024 HK$58.76 M-104.99%
2023 -HK$1.18 Billion-15.03%
2022 -HK$1.39 Billion-20.61%
2021 -HK$1.75 Billion84.28%
2020 -HK$0.95 Billion35.75%
2019 -HK$0.7 Billion-55.71%
2018 -HK$1.58 Billion19.57%
2017 -HK$1.32 Billion125.39%
2016 -HK$0.59 Billion51.43%
2015 -HK$0.39 Billion36.45%
2014 -HK$0.29 Billion43.55%
2013 -HK$0.2 Billion145.26%
2012 -HK$80.29 Million
2002 -HK$0.23 Billion-7.81%
2001 -HK$0.25 Billion15.03%
2000 -HK$0.22 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$82.91 B-38,695.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$40.37 B-18,892.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-HK$4.21 Billion 1,855.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-HK$0.54 Billion 149.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
HK$1.49 M-100.70%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$3.01 B-1,505.17%๐Ÿ‡บ๐Ÿ‡ธ USA